Autoimmune Diseases-MKGIMI BIOTECH

Autoimmune Diseases

Home / NCI Project / Autoimmune Diseases

Trial title

Estimated Enrollment

Partner

NCT07046338 Lentiviral Vector-modified Autologous Hematopoietic Stem Cells for Metachromatic Leukodystrophy (MLD)'

Estimated Enrollment:
10
NCT06435897 Management of Autoimmune Conditions With Mesenchymal Stem Cells (MSCs)and CAR-T Cells'

Estimated Enrollment:
30
NCT05459870 CAR-T Cells Targeting B Cell Related Autoimmune Diseases'

Estimated Enrollment:
30
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine'

Estimated Enrollment:
100
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine'

Estimated Enrollment:
100
NCT03351855 Phase I/II and Multicenter Trial of HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of Human Papilloma Virus (HPV) Infection'

Estimated Enrollment:
100
NCT03123458 Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders'

Estimated Enrollment:
100